EC Number   |
Inhibitors  |
Structure |
|---|
    1.3.98.1 | 1,5-dihydrofuro[3,4-d]pyrimidine-2,4,7-trione |
- |
   |
| 1.3.98.1 | 1-(1-naphthyl)-3-[2-(trifluoromethyl)phenyl]urea |
50% inhibition at 0.0004 mM, wild type, 0.00034 mM, mutant R265A, above 0.2, mutant H185A |
|
| 1.3.98.1 | 1-(2-methoxyphenyl)-3-(1-naphthyl)urea |
50% inhibition at 0.00023 mM, wild type, 0.00024 mM, mutant R265A, 0.140, mutant H185A |
|
| 1.3.98.1 | 1-(4-Chloro-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 3-(4-methyl-benzylamide) 5-phenylamide |
minimum inhibitory concentration 0.032 mg/ml |
|
| 1.3.98.1 | 1-(4-Chloro-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 3-benzylamide 5-(isobutyl-amide) |
minimum inhibitory concentration above 0.064 mg/ml |
|
| 1.3.98.1 | 1-(4-Chloro-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 3-benzylamide 5-[(4-carbamoyl-phenyl)-amide] |
minimum inhibitory concentration 0.008 mg/ml |
|
| 1.3.98.1 | 1-(4-Chloro-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 5-phenylamide 3-[(pyridin-3-ylmethyl)-amide] |
minimum inhibitory concentration 0.00025 mg/ml |
|
| 1.3.98.1 | 1-(4-Chloro-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 5-[(4-piperidin-1-yl-phenyl)-amide] 3-[(pyridin-3-ylmethyl)-amide] |
minimum inhibitory concentration 0.002 mg/ml |
|
| 1.3.98.1 | 1-(4-chlorophenyl)-3-quinolin-8-ylurea |
50% inhibition at 0.00078 mM, wild type, 0.002 mM, mutant R265A, above 0.4, mutant H185A |
|
| 1.3.98.1 | 1-(4-Methoxy-phenyl)-1H-pyrazole-3,5-dicarboxylic acid 3-(isobutyl-amide) 5-[[4-(pyrrolidine-1-carbonyl)-phenyl]-amide] |
minimum inhibitory concentration 0.064 mg/ml |
|
